Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dávid Balázsi"'
Autor:
Dávid Balázsi, Zoltán Tóth, Jeffrey B. Locke, Andrew M. Borman, Lajos Forgács, Noémi Balla, Fruzsina Kovács, Renátó Kovács, Chiaki Amano, Tugba Ilay Baran, László Majoros
Publikováno v:
Journal of Fungi, Vol 10, Iss 9, p 617 (2024)
Objectives: Rezafungin is the first new drug approved to treat candidaemia and invasive candidiasis in more than 10 years. However, data are scant on the in vivo efficacy of rezafungin and the other three approved echinocandins against different Cand
Externí odkaz:
https://doaj.org/article/ca17088ce19e49fc9a9f6f8d23363b35
Autor:
Noémi Balla, Ágnes Jakab, Fruzsina Kovács, Ágota Ragyák, Zoltán Tóth, Dávid Balázsi, Lajos Forgács, Aliz Bozó, Farah Al Refai, Andrew M Borman, László Majoros, Renátó Kovács
Publikováno v:
AMB Express, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Tyrosol, a secondary metabolite of Candida species, regulates fungal morphogenesis, and its application may represent a novel innovative therapy against emerging multi-resistant fungal superbug such as Candida auris. In the current study, th
Externí odkaz:
https://doaj.org/article/93532682ce414942898fa3907c3d79fd
Autor:
Awid Adnan, Andrew M. Borman, Zoltán Tóth, Lajos Forgács, Renátó Kovács, Dávid Balázsi, Bence Balázs, Gergely Udvarhelyi, Gábor Kardos, László Majoros
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1365 (2023)
Candida auris is a multidrug-resistant pathogen against which echinocandins are the drug of choice. However, information on how the chitin synthase inhibitor nikkomycin Z influences the killing activities of echinocandins against C. auris is currentl
Externí odkaz:
https://doaj.org/article/9f4049b00f6144a6ae5201a8b1483d87
Autor:
Lajos Forgács, Andrew M. Borman, Renátó Kovács, Dávid Balázsi, Zoltán Tóth, Bence Balázs, Chiu Chun-Ju, Gábor Kardos, Ilona Kovacs, László Majoros
Publikováno v:
Journal of Fungi, Vol 8, Iss 5, p 499 (2022)
Candida auris is a multidrug-resistant fungus against which in some clinical situations amphotericin B (AMB) remains the alternative or first line drug. We compared daily 1 mg/kg of AMB efficacy in a neutropenic murine bloodstream infection model aga
Externí odkaz:
https://doaj.org/article/3e473820fcaf4d08a28906395e9d54c7
Autor:
Majoros, Lajos Forgács, Andrew M. Borman, Renátó Kovács, Dávid Balázsi, Zoltán Tóth, Bence Balázs, Chiu Chun-Ju, Gábor Kardos, Ilona Kovacs, László
Publikováno v:
Journal of Fungi; Volume 8; Issue 5; Pages: 499
Candida auris is a multidrug-resistant fungus against which in some clinical situations amphotericin B (AMB) remains the alternative or first line drug. We compared daily 1 mg/kg of AMB efficacy in a neutropenic murine bloodstream infection model aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::f76fcd101f19ace9ccff5d2bb3be3b9a